IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Saroja Pharma Industries India IPO listing price is ₹ 68.25, issue price is ₹ 84.00, and currently trading at ₹ 35.80 as on July 30, 2025. Saroja Pharma Industries India IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Saroja Pharma Industries India IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Chemical - Speciality sector. Swastika Investmart is the merchant banker of Saroja Pharma Industries India IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 15th June 2023.
Saroja Pharma Industries India IPO offer price is ₹ 84.00 and got listed at ₹ 68.25. Read Saroja Pharma Industries India IPO details mentioned above.The IPO of Saroja Pharma Industries India Limited was listed on 13th September 2023. As of today, Saroja Pharma Industries India IPO is trading at ₹ 35.80, compared to the previous day’s close of ₹ 36.05. Read the report above for detailed IPO performance.
The issue price of Saroja Pharma Industries India IPO was ₹ 84.00 per equity share.
Saroja Pharma Industries India IPO was listed at ₹68.25 on the stock exchange on 13th September 2023. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of July 30, 2025, the current market price of Saroja Pharma Industries India IPO is ₹ 35.80.
The 52-week high for Saroja Pharma Industries India IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Saroja Pharma Industries India IPO listed at ₹ 68.25 against the issue price of ₹ 84.00 per equity share, showing a listing day gain/loss of -15.75 (-18.75%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Saroja Pharma Industries India IPO stock moved from its listing price of ₹ 68.25 to the current price of ₹35.80 per equity share, reflecting a change of -47.55% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Saroja Pharma Industries India IPO issue date of 13th September 2023 and CMP of ₹35.80, the estimated CAGR is approximately -36.44%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 84.00
Listing Price :
₹ 68.25
Previous Day Closing
₹ 36.05
Saroja Pharma Industries India IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Saroja Pharma Industries India Financial Review Page
Merchant Banker(s) of Saroja Pharma Industries India IPO: Swastika Investmart Limited
Saroja Pharma Industries India IPO subscription was 8.88 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Saroja Pharma Industries India IPO listed at a listing price of 68.25 against the offer price of 84.00.
The current market price of Saroja Pharma Industries India is 35.80.
Why Us?
